ITGB1 and acute lymphoblastic leukemia: Park et al. show that ALL interaction with mesenchymal stromal cells is mediated by integrin beta 1 and drives an EMT phenotype that activates WNT/β-catenin signaling that may be targeted to ameliorate drug resistance.